GlassScriptPhysician profile
Adam Raskin
NPI 1225264914
$110,620.60
in general payments reported to CMS, 2019-2025
50 companies · $8,570 in 2025
The $8,570 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,224 · 2020: $3,823 · 2021: $13K · 2022: $16K · 2023: $39K · 2024: $27K · 2025: $8,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Food and Beverage: $20K · Consulting Fee: $17K · Travel and Lodging: $5,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,200.00 |
| Food and Beverage | $19,871.41 |
| Consulting Fee | $17,317.00 |
| Travel and Lodging | $5,280.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $50,546.31 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Imperative Care, INC | $27,247.84 | 2023-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter, Prodigy Catheter |
| Abiomed | $7,436.15 | 2019-2025 | Impella |
| Truvic Medical, INC. | $6,724.51 | 2022 | |
| Abbott Laboratories | $5,750.45 | 2019-2025 | Esprit, 2nd Gen Centrimag Primary Console, Xact |
| Boston Scientific Corporation | $2,011.34 | 2019-2024 | Watchman Access System, Varithena Administration Pack, Rotablator Rotational Atherectomy System Console Kit |
| Janssen Pharmaceuticals, INC | $1,181.73 | 2020-2023 | Xarelto |
| Medtronic Vascular, INC. | $1,109.70 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,034.89 | 2020-2025 | |
| Amgen INC. | $656.15 | 2020-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $616.76 | 2019-2025 | Lifevest |
| Livanova USA, INC. | $563.53 | 2020-2023 | Lifesparc |
| Bard Peripheral Vascular, INC. | $542.80 | 2021-2024 | Venclose Maven Catheter, Venovo, Lifestream |
| Cardiovascular Systems INC. | $530.28 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $431.06 | 2019-2023 | Farxiga |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $406.30 | 2019-2023 | Jardiance |
| Cvrx, INC. | $368.74 | 2023-2025 | Barostim Neo System |
| Avinger INC. | $326.85 | 2019-2022 | |
| Esperion Therapeutics, INC. | $313.82 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $306.11 | 2020-2022 | |
| Tactile Systems Technology INC | $299.53 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Angiodynamics, INC. | $283.72 | 2020-2021 | |
| Medtronic, INC. | $278.92 | 2021-2022 | |
| Penumbra, INC. | $213.06 | 2019-2022 | |
| Shockwave Medical, INC | $199.19 | 2021-2025 | |
| Terumo Medical Corporation | $115.61 | 2024 | |
| Pfizer INC. | $98.64 | 2022-2023 | |
| Cardiva Medical, INC. | $97.66 | 2024 | Optowire, Cardiva Vascade 6/7f Vcs |
| Ethicon INC. | $95.13 | 2023 | Harmonic |
| Merck Sharp & Dohme LLC | $94.22 | 2021-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $82.24 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $71.75 | 2021-2023 | Uptravi, Opsumit |
| Vifor Pharma, INC. | $71.22 | 2020-2021 | |
| Chiesi USA, INC. | $70.37 | 2020-2022 | |
| Stryker Corporation | $49.86 | 2025 | Artix Mt, Flowtriever |
| Philips North America LLC | $49.25 | 2023-2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| Organogenesis INC. | $47.92 | 2024 | |
| Edwards Lifesciences Corporation | $47.30 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $43.40 | 2021-2025 | Camzyos |
| Daiichi Sankyo INC. | $38.19 | 2020-2022 | |
| Astellas Pharma US INC | $27.33 | 2021 | |
| Endologix LLC | $23.40 | 2024 | Torus Stent Graft System, Endocross Device |
| Cordis US Corp. | $17.62 | 2025 | Mynx Control Venous |
| Vital Connect, INC | $17.40 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $16.42 | 2023 | Inpefa |
| Novo Nordisk INC | $15.93 | 2023 | Ozempic |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Csl Behring | $13.47 | 2023 | Kcentra |
| Ge Healthcare | $13.11 | 2021 | |
| Acist Medical Systems, INC. | $8.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$148.02 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Raskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.